EXTRAADRENAL EFFECTS OF METYRAPONE INCLUDE INHIBITION OF THE 11-OXOREDUCTASE ACTIVITY OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE - A MODEL FOR 11-HSD-I DEFICIENCY

被引:40
作者
RAVEN, PW [1 ]
CHECKLEY, SA [1 ]
TAYLOR, NF [1 ]
机构
[1] UNIV LONDON KINGS COLL HOSP,DEPT CLIN BIOCHEM,LONDON SE5 9PJ,ENGLAND
关键词
D O I
10.1111/j.1365-2265.1995.tb02930.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND OBJECTIVE Previous studies suggesting effects of metyrapone on extra-adrenal corticosteroid metabolism have involved significant alterations in plasma cortisol. We have therefore studied effects of metyrapone on urinary excretion of steroids in a group of patients treated concurrently with hydrocortisone so that changes in plasma cortisol were minimized. DESIGN Replacement doses of hydrocortisone (30 mg/day) were given concurrently with metyrapone (2-4 g/day) for 2 weeks. Blood samples were taken and 24-hour urinary steroid collections were made at baseline and after 1 and 2 weeks of treatment. PATIENTS Subjects were 6 female patients with major depression from a trial of metyrapone as an antidepressant. MEASUREMENTS Urinary steroid profiles were measured by gas chromatography; plasma cortisol and urinary free cortisol were measured by fluorescence immunoassay. RESULTS Plasma cortisol levels were not significantly decreased by treatment, while excretion of 11-deoxycortisol metabolites increased eightfold after 2 weeks indicating that concurrent hydrocortisone administration had not suppressed the adrenal. Ratios reflecting 11 beta-hydroxy/11-oxo metabolites of cortisol were significantly decreased, consistent with inhibition of the 11-oxoreductase activity of 11 beta-hydroxysteroid dehydrogenase (11-HSD). Other changes included significant decreases in the rates of 5 alpha vs 5 beta and of 20 alpha vs 20 beta reduction of corticosteroids. CONCLUSIONS Metyrapone has multiple effects on extra-adrenal corticosteroid metabolism and is the only agent we know of which selectively inhibits 11-oxoreductase. Metyrapone thus provides a model for 11-HSD I deficiency and a tool for in-vitro studies of cortisol-cortisone interconversion. The results also suggest mechanisms whereby corticosteroid effects can be regulated separately from corticosteroid synthesis.
引用
收藏
页码:637 / 644
页数:8
相关论文
共 29 条
[1]   ABNORMAL STEROID-EXCRETION IN GESTATIONAL TROPHOBLASTIC DISEASE COMPLICATED BY OVARIAN THECA-LUTEIN CYSTS [J].
BEVAN, BR ;
SAVVAS, M ;
JENKINS, JM ;
BAKER, K ;
PENNINGTON, GW ;
TAYLOR, NF .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (06) :627-634
[2]   EFFECTS OF METYRAPONE AND CORTICOTROPIN INFUSION ON CORTISOL DISAPPEARANCE RATE IN MAN [J].
BLICHERT.M ;
NIELSEN, ML ;
FOLKE, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1972, 35 (01) :59-+
[3]   STEROID PROFILES IN URINE AND PLASMA OF ALCOHOLICS DURING WITHDRAWAL [J].
CRONHOLM, T ;
CURSTEDT, T ;
SCHMIDT, DN ;
SJOVALL, J .
ALCOHOL, 1985, 2 (05) :677-682
[4]   CLINICAL, ENDOCRINOLOGICAL, AND ENZYMATIC CHARACTERIZATION OF 2 PATIENTS WITH 5ALPHA-REDUCTASE DEFICIENCY - EVIDENCE THAT A SINGLE ENZYME IS RESPONSIBLE FOR 5-ALPHA-REDUCTION OF CORTISOL AND TESTOSTERONE [J].
FISHER, LK ;
KOGUT, MD ;
MOORE, RJ ;
GOEBELSMANN, U ;
WEITZMAN, JJ ;
ISAACS, H ;
GRIFFIN, JE ;
WILSON, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 47 (03) :653-664
[6]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[7]   C19 AND C21 5-BETA 5-ALPHA-METABOLITE RATIOS IN SUBJECTS TREATED WITH THE 5-ALPHA-REDUCTASE INHIBITOR FINASTERIDE - COMPARISON OF MALE PSEUDOHERMAPHRODITES WITH INHERITED 5-ALPHA-REDUCTASE DEFICIENCY [J].
IMPERATOMCGINLEY, J ;
SHACKLETON, C ;
ORLIC, S ;
STONER, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (03) :777-782
[8]  
LATIF S A, 1990, Steroids, V55, P52, DOI 10.1016/0039-128X(90)90024-6
[9]   EXTRA-ADRENAL EFFECTS OF METYRAPONE IN MAN [J].
LEVIN, J ;
ZUMOFF, B ;
FUKUSHIMA, DK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 47 (04) :845-849
[10]   TREATMENT OF MAJOR-DEPRESSION WITH METYRAPONE AND HYDROCORTISONE [J].
ODWYER, AM ;
LIGHTMAN, SL ;
MARKS, MN ;
CHECKLEY, SA .
JOURNAL OF AFFECTIVE DISORDERS, 1995, 33 (02) :123-128